Peter A. Ljubenkov
Impact in
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments
- Amyotrophic Lateral Sclerosis Research
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological disorders and treatments
-
- Alzheimer's disease research and treatments
Papers in
-
- Alzheimer's disease research and treatments 8
-
- Amyotrophic Lateral Sclerosis Research 5
- Parkinson's Disease Mechanisms and Treatments 4
- Neurological disorders and treatments 1
- Co-authors
- Adam L. Boxer (13 shared papers)Lawren VandeVrede (10 shared papers)Bruce L. Miller (5 shared papers)Julio C. Rojas (9 shared papers)Michael D. Geschwind (1 shared paper)Gil D. Rabinovici (4 shared papers)Mary Koestler (4 shared papers)Renaud La Joie (4 shared papers)
- Journals
- Alzheimer s & Dementia (6 papers)Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2 papers)Frontiers in Neurology (2 papers)Nature Medicine (1 paper)Neurotherapeutics (1 paper)
- Partner nations
- United StatesNetherlandsSouth Korea
In The Last Decade
Peter A. Ljubenkov
18 papers receiving 223 citations
Peers
Comparison fields: 5 of 57
- Neurology 83
- Neurology 37
- Physiology 113
- Biological Psychiatry 9
- Psychiatry and Mental health 36
Countries citing papers authored by Peter A. Ljubenkov
This map shows the geographic impact of Peter A. Ljubenkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Ljubenkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Ljubenkov more than expected).
Fields of papers citing papers by Peter A. Ljubenkov
This network shows the impact of papers produced by Peter A. Ljubenkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Ljubenkov. The network helps show where Peter A. Ljubenkov may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter A. Ljubenkov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 52 | |
| 2 | 2020 | 44 | |
| 3 | 2020 | 30 | |
| 4 | 2024 | 23 | |
| 5 | 2016 | 18 | |
| 6 | 2016 | 18 | |
| 7 | 2019 | 15 | |
| 8 | 2019 | 9 | |
| 9 | 2023 | 7 | |
| 10 | 2022 | 3 | |
| 11 | 2020 | 3 | |
| 12 | 2024 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2021 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2025 | 0 |
About Peter A. Ljubenkov
Peter A. Ljubenkov is a scholar working on Physiology, Neurology, Molecular Biology, Psychiatry and Mental health and Pharmacology, having authored 19 papers that have together received 229 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (8 papers), Amyotrophic Lateral Sclerosis Research (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), S100 Proteins and Annexins (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Epilepsy research and treatment (1 paper), Neurological disorders and treatments (1 paper) and Dementia and Cognitive Impairment Research (1 paper). The work is most often cited by research in Neurology (83 citations), Neurology (37 citations), Physiology (113 citations), Biological Psychiatry (9 citations) and Psychiatry and Mental health (36 citations). Peter A. Ljubenkov has collaborated with scholars based in United States, Netherlands and South Korea. Frequent co-authors include Adam L. Boxer, Lawren VandeVrede, Bruce L. Miller, Julio C. Rojas, Michael D. Geschwind, Gil D. Rabinovici, Mary Koestler, Renaud La Joie, Ariane E. Welch and David N. Soleimani‐Meigooni. Their work appears in journals such as Alzheimer s & Dementia, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, Frontiers in Neurology, Nature Medicine and Neurotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.